Alireza Aslani

Paul J Roach2
Elizabeth A Bailey2
Graeme M Snowdon2
Dale L Bailey2
Geoffrey P Schembri2
2Paul J Roach
2Elizabeth A Bailey
2Graeme M Snowdon
2Dale L Bailey
2Geoffrey P Schembri
Learn More
OBJECTIVES Peptide Receptor Radionuclide Therapy (PRRT) with yttrium-90 ((90)Y) and lutetium-177 ((177)Lu)-labelled SST analogues are now therapy option for patients who have failed to respond to conventional medical therapy. In-house production with automated PRRT synthesis systems have clear advantages over manual methods resulting in increasing use in(More)
BACKGROUND Advances in gamma camera technology and the emergence of a number of new theranostic radiopharmaceutical pairings have re-awakened interest in in vivo quantification with single-photon-emitting radionuclides. We have implemented and validated methodology to provide quantitative imaging of (177)Lu for 2D whole-body planar studies and for 3D(More)
Technology intelligence is important among the management researchers in order to present best service and product, increase diversity and flexibility, and speed the process of production and innovation. On the other hand, identification of the situation of organizations in technology intelligence is a key subject in the researches. This research is a(More)
OBJECTIVES Gallium-68 (Ga-68) is an ideal research and hospital-based PET radioisotope. Currently, the main form of Ga-68 radiopharmaceutical that is being synthesised in-house is Ga-68 conjugated with DOTA based derivatives. The development of automated synthesis systems has increased the reliability, reproducibility and safety of radiopharmaceutical(More)
  • 1